Merit Medical Systems (MMSI) Cost of Revenue (2010 - 2026)

Merit Medical Systems has disclosed Cost of Revenue across 17 years of filings, most recently posting $197.1 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $197.1 million, up 7.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $791.4 million (up 9.2% YoY), and the FY2025 annual result was $777.6 million, up 9.04% from the prior year.
• Cost of Revenue came in at $197.1 million for Q1 2026 at Merit Medical Systems, down from $198.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $198.6 million in Q4 2025 to a low of $154.5 million in Q1 2022.
• The 5-year median for Cost of Revenue is $174.0 million (2023), against an average of $176.1 million.
• Peak annual rise in Cost of Revenue reached 12.76% in 2022, while the deepest fall reached 2.38% in 2022.
• Merit Medical Systems' Cost of Revenue stood at $158.9 million in 2022, then increased by 9.52% to $174.0 million in 2023, then rose by 4.71% to $182.2 million in 2024, then rose by 9.01% to $198.6 million in 2025, then slipped by 0.76% to $197.1 million in 2026.
• The last three Cost of Revenue figures came in at $197.1 million (Q1 2026), $198.6 million (Q4 2025), and $197.7 million (Q3 2025), per Business Quant data.